Skip to main content
. 2020 Apr 23;2020:3987065. doi: 10.1155/2020/3987065

Table 6.

League table of the LDL-C network meta-analysis results among placebo and 7 statins. (Results with statistical significance are shown in bold.).

Rosuvastatin Atorvastatin Pitavastatin Simvastatin Pravastatin Fluvastatin Lovastatin Placebo
Rosuvastatin Rosuvastatin 5.87 (-5.72, 17.47) 8.26 (-12.46, 28.98) 15.35 (-0.24, 30.95) 16.15 (-2.87, 35.16) 23.03 (-4.12,50.19) 33.67 (-9.49, 76.83) 72.28 (57.08, 87.48)
Atorvastatin -5.87 (-17.47, 5.72) Atorvastatin 2.38 (-16.71, 21.48) 9.48 (-2.91, 21.88) 10.27 (-7.68, 28.22) 17.16 (-7.82,42.14) 27.79 (-14.15, 69.74) 66.40 (55.10, 77.71)
Pitavastatin -8.26 (-28.98, 12.46) -2.38 (-21.48, 16.71) Pitavastatin 7.10 (-12.51, 26.71) 7.89 (-14.86, 30.63) 14.78 (-16.04,45.59) 25.41 (-20.05, 70.87) 64.02 (43.17, 84.87)
Simvastatin -15.35 (-30.95, 0.24) -9.48 (-21.88, 2.91) -7.10 (-26.71, 12.51) Simvastatin 0.79 (-18.99, 20.57) 7.68 (-18.77, 34.12) 18.31 (-24.09, 60.71) 56.92 (44.05, 69.80)
Pravastatin -16.15 (-35.16, 2.87) -10.27 (-28.22, 7.68) -7.89 (-30.63, 14.86) -0.79 (-20.57, 18.99) Pravastatin 6.89 (-23.21, 36.99) 17.52 (-27.45, 62.49) 56.13 (36.37, 75.89)
Fluvastatin -23.03 (-50.19, 4.12) -17.16 (-42.14, 7.82) -14.78 (-45.59, 16.04) -7.68 (-34.12, 18.77) -6.89 (-36.99, 23.21) Fluvastatin 10.64 (-36.38, 57.66) 49.25 (25.19, 73.31)
Lovastatin -33.67 (-76.83, 9.49) -27.79 (-69.74, 14.15) -25.41 (-70.87, 20.05) -18.31 (-60.71, 24.09) -17.52 (-62.49, 27.45) -10.64 (-57.66, 36.38) Lovastatin 38.61 (-1.79, 79.01)
Placebo -72.28 (-87.48, -57.08) -66.40 (-77.71, -55.10) -64.02 (-84.87, -43.17) -56.92 (-69.80, -44.05) -56.13 (-75.89, -36.37) -49.25 (-73.31, -25.19) -38.61 (-79.01, 1.79) Placebo